What Every Primary Care Clinician Should Know About Rheumatoid Arthritis
Type: Session Therapeutic: Rheumatology
Friday May 11 10:15am to 11:15am Location: Lecture Hall 2 Credits: 1 Mainpro+
Rheumatoid arthritis (RA) affects 1% of the general population, and its prevalence is increasing. New therapies and therapeutic strategies have improved RA outcomes dramatically. We will review the following topics:
What happens with lack of disease control?
How do we measure the disease?
Why early aggressive therapy?
What is new?
What is coming?
GP/FP role in RA
Recognize the critical importance of early referral in RA.
Understand the effects of co-morbidities in your RA patients.
Understand improved outcomes with biologic and targeted therapies and a treat-to-target approach.
Philip A. Baer MDCM, FRCPC, FACR Dr. Philip Baer is a graduate of McGill University’s Faculty of Medicine, where he was the class gold medallist. He trained in Internal Medicine at the Montreal General Hospital, followed by a rheumatology fellowship at the University of Toronto, supported by the Arthritis Society. Dr. Baer has practised as a clinical rheumatologist in eastern Toronto for over 25 years. He is an active participant in clinical registries and Continuing Medical Education. Dr. Baer is Medical Director of ivari and Canadian Premier Life, a member of the Executive of the Ontario Rheumatology Association (ORA), Chair of the Section of Rheumatology of the Ontario Medical Association (OMA), and Editor-in-chief of the Journal of the Canadian Rheumatology Association (CRA). In 2011, Dr. Baer was recognized as the GTA Community Rheumatologist of the Year by the Division of Rheumatology, University of Toronto. In 2012, Dr. Baer received the OMA Section Service Award and was recognized as the Rheumatologist-of-the-Year by the ORA. In 2016, Dr. Baer received the CRA Practice Reflection Silver Award.